NCT00466232 2015-12-16
Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer
HealthPartners Institute
Phase 1 Completed
HealthPartners Institute
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC